HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

CMS Publishes Post-PHE Audit Guidance

November 10, 2022 by David Kopf

CMS has released its first official guidance concerning how it will handle Medicare claims audits after the end of the Covid-19 public health emergency (PHE).

According to CMS, the guidance would impact how Medicare Administrative Contractors (MACs), Recovery Audit Contractors (RACs) and the Supplemental Medical Review Contractor (SMRC) plan to conduct medical reviews post-PHE.

During the PHE, CMS applied policy flexibilities across various types of claims. That flexibility included not enforcing clinical indications for coverage for claims on certain DME items provided during the PHE, according to CMS.

Because it implemented those flexibilities, CMS said that once the PHE ends, it plans to have audit contractors primarily focus reviews on claims with dates of service outside of the PHE, for which clinical indications of coverage are applicable.

“We note that we may still review these DME items, as well as other items or services rendered during the PHE, if needed to address aberrant billing behaviors or potential fraud,” CMS guidance read. “The HHS Office of the Inspector General may perform reviews as well. All claims will be reviewed using the applicable rules in place at the time for the claim dates of service.”

“AAHomecare has been in contact with CMS concerning the transition out of the PHE and will continue to work with CMS and Medicare contractors as the end of the PHE nears,” a statement from the American Association for Homecare read.

So when does the PHE end? At present, the date when the Covid-19 PHE ends is unknown. In late October, Secretary of Health and Human Services Xavier Becerra extended the Covid-19 PHE for another 90 days until Jan. 11, 2023.

We also know that in a May 10 letter to U.S. governors, Becerra reaffirmed HHS’s commitment to providing at least 60 days advance notice before ending the PHE. Based on that information, it can be assumed that all eyes will be on HHS in roughly a week or two to see if HHS will give that notice. If not, we can assume there will be another extension.

But what is making some people expect the PHE to end is the fact that in late August, CMS released a summary “roadmap” and other resources to help providers and suppliers start preparing for the regulatory environment that will come after the Covid-19 public health emergency ends. It’s likely CMS wouldn’t make such an announcement, or the recent audit guidance, without an end to the PHE coming into focus.

For now, all eyes are on HHS for that 60-day notice.

Related Articles Read More >

NCPA Announces New Senior Vice President of the Office of CEO
Sara Roszak is an industry veteran who most recently served at the National Association of Chain Drug Stores.
More HCPCS Codes to Be Added to Medicare Prior Authorization Process in October
Prior authorization will be required for eight additional codes for dates of service of Oct. 28 and later.
M&A Update, Part 2: What Makes a Good Investment or Acquisition?
At the HME Business FUTURE conference, experts on mergers and acquisitions took the stage.
Frazier Healthcare Acquires MatrixCare, Appoints CEO
MatrixCare was owned by Resmed.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe